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Abstract
Background: The leaf juice or water decoction of Catharanthus roseus L. (Apocyanaceae) is used
as a folk medicine for the treatment of diabetes all over the world. In the present investigation, the
leaf juice of C. roseus has been evaluated for its hypoglycemic activity in normal and alloxan-induced
diabetic rabbits.
Methods: The blood glucose lowering activity of the leaf juice was studied in normal and alloxan-
induced (100 mg/kg, i.v.) diabetic rabbits, after oral administration at doses of 0.5, 0.75 and 1.0 ml/
kg body weight. Blood samples were collected from the marginal ear vein before and also at 4, 6,
8, 10, 12, 16, 18, 20 & 24 h after drug administration and blood glucose was analyzed by Nelson-
Somogyi's method using a visible spectrophotometer. The data was compared statistically by using
Student's t-test.
Results: The leaf juice of C. roseus produced dose-dependent reduction in blood glucose of both
normal and diabetic rabbits and comparable with that of the standard drug, glibenclamide. The
results indicate a prolonged action in reduction of blood glucose by C. roseus and the mode of action
of the active compound(s) of C. roseus is probably mediated through enhance secretion of insulin
from the β-cells of Langerhans or through extrapancreatic mechanism.
Conclusions: The present study clearly indicated a significant antidiabetic activity with the leaf
juice of Catharanthus roseus and supports the traditional usage of the fresh leaves by Ayurvedic
physicians for the control of diabetes.
Background
Diabetes mellitus is a major endocrine disorder affecting
nearly 10% of the population all over the World [1].
Inspite of the introduction of hypoglycemic agents, diabe-
tes and the related complications continue to be a major
medical problem. Since time immemorial, patients with
non-insulin dependent diabetes mellitus have been
treated orally by folklore with a variety of plant extracts. In
the indigenous Indian system of medicine (Ayurveda), a
mention was made on good number of plants for the cure
of diabetes or 'madhumeha' and some of them have been
experimentally evaluated and the active principles were
isolated [2–8]. However, search for new antidiabetic drugs
continues.
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Catharanthus roseus (L.) G. Don (Apocyanaceae) is known
with various names (Madagascar periwinkle; Vinca rosea;
Lochnera rosea) in India and all over the world. Water
decoction of the leaves and/or the whole plant is used as
household remedy for diabetes in several countries [9].
Traditionally, in India seven flowers/leaves are used at a
time whereas in the Cook Islands 18 leaves boiled in a ket-
tle of water and in West Indies roots of plants infused in
whiskey are used to control diabetes [10–12]. Earlier
reports indicate significant blood glucose lowering activ-
ity with hydroalcoholic or dichloromethane-methanol
extracts of leaves of C. roseus in laboratory animals [13–
19]. The use of fresh leaf juice of C. roseus has been in prac-
tice by Ayurvedic physicians in India with beneficial
action. Hence, in the present study the leaf juice of C.
roseus has been evaluated for hypoglycemic activity in nor-
mal and alloxan diabetic rabbits.
Methods
Plant material
Fresh leaves of C. roseus (white variety) were collected
from our University campus and were crushed in a stain-
less steel mortar and squeezed by means of a fine cloth to
separate the juice. The authenticity of the plant was done
by botanist Dr. M. Venkaiah, Department of Botany, And-
hra University and the voucher specimen was kept in the
herbarium (No. 0614) of our University.
Chemicals Used
Glibenclamide was provided as a generous gift sample by
Hoechst Pharmaceuticals, Mumbai, while alloxan (Sigma
Chemical Company, USA) was a generous gift sample
from Dr. Reddy's Laboratories, Hyderabad. All other rea-
gents used were of analytical grade.
Animal Experiments
Adult albino rabbits (B.N. Ghosh & Co., Kolkata) of either
sex weighing 1.5 – 2 kg were used in the study. They were
divided into 10 groups of five each and were provided
with a standard diet and water ad libitum. All the rabbits
were kept in cages with wide square mesh at the bottom
to avoid coprophagy and maintained in a well-ventilated
animal house with 12 h light and dark cycle. They were
fasted for 18 h prior to the experiment, allowing access to
water only, and were deprived of both food and water dur-
ing the 24 h monitoring period of the experiment after the
treatment either with the drug or distilled water (control)
to minimize the changes in plasma volume. The same
procedure has been followed for each treatment. The
experimental protocol has been approved by the Institu-
tional Animal Ethics Committee and by the animal regu-
latory body of the government (Regd. No. 516/01/A/
CPCSEA)
Groups I to IV consist of normal animals, as well as the
normal control, group V. Groups I, II & III were given the
leaf juice of C. roseus orally through intragastric intubation
at doses of 0.5, 0.75 and 1.0 ml/kg body weight respec-
tively. The gastric tube was washed with distilled water
after drug administration, such that each animal received
a total volume of 3 ml. Group IV was given glibenclamide
at a dose of 40 µg/kg orally in a total volume of 3 ml for
each animal. Group V, the normal control received 3 ml
of distilled water.
Groups VI to X were rendered diabetic by injecting alloxan
(100 mg/kg, i.v) into the marginal ear vein after a base
line blood glucose (95.3, 99.7, 105.1, 91.0 and 101.3 mg/
dl respectively) estimation was done. After two weeks
when the condition of diabetes was stabilized, rabbits
with blood glucose above 300 mg/dl were selected for the
study.
Animals in groups VI, VII & VIII received the leaf juice of
C. roseus orally at doses of 0.5, 0.75 and 1.0 ml/kg respec-
tively. Group IX received glibenclamide orally at a dose of
40 µg/kg. Group X served as diabetic control.
Collection of blood and analytical procedure
Blood samples (approx. 0.3 ml) were collected by punc-
turing the marginal ear vein of each rabbit of a group
before and also at 4, 6, 8, 10, 12, 16, 18, 20 & 24 h after
oral administration of the drug. The samples were col-
lected into glass vials containing a small quantity of a mix-
ture of potassium oxalate and sodium fluoride as anti-
coagulant. They were stored at 4°C in a refrigerator before
the analysis of glucose by Nelson-Somogyi's method [20–
22] using a visible spectrophotometer.
Data and Statistical Analysis
Data was expressed as mean ± standard error of means.
Statistical analysis was made by using Student's unpaired
t-test.
Results
The leaf juice of C. roseus produced a dose-dependent
hypoglycemia in normal rabbits. It produced maximum
reduction in blood glucose of 16.7% (6 h, p < 0.05),
28.6% (18 h, p < 0.05), and 31.9% (20 h, p < 0.01) with
doses of 0.5, 0.75 and 1.0 ml/kg body weight respectively
(Table 1). Glibenclamide (40 µg/kg) produced a signifi-
cant (p < 0.01) reduction in blood glucose compared to
control (31.9%, 8 h).
Dose-dependent reduction in blood glucose was also
observed in alloxan-induced diabetic rabbits treated with
C. roseus. The percent reduction in blood glucose tended
to be higher in the diabetic condition compared to the
normal state. A significant reduction (p < 0.001) in bloodBMC Complementary and Alternative Medicine 2003, 3 http://www.biomedcentral.com/1472-6882/3/4
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glucose of 19.6% (8 h), 31.4% (18 h) and 36.5% (20 h)
was observed with C. roseus at doses of 0.5, 0.75 and 1.0
ml/kg body weight respectively (Table 2). Glibenclamide
(40 µg/kg) produced a significant reduction (p < 0.001) in
blood glucose compared to diabetic control at the 8 h
(34.9%).
Discussion
Diabetes mellitus is possibly the world's largest growing
metabolic disease, and as the knowledge on the heteroge-
neity of this disorder is advanced, the need for more
appropriate therapy increases [23]. Traditional plant med-
icines are used throughout the world for a range of dia-
betic complications. The study of such medicines might
offer a natural key to unlock a diabetologist's pharmacy
for the future.
Leaves and flowers of C. roseus are used traditionally by
diabetic patients in India and are taken as water decoc-
tion. Due to this reason the leaf juice of the plant was eval-
uated and the data also confirmed the traditional
indications. Earlier investigations [13–19] on the antidia-
betic activity of the organic extracts of C. roseus by various
authors also substantiate the results of our studies in rab-
bits. Moreover, the fact that the juice has a more pro-
longed effect (at 1.0 ml/kg) than the glibenclamide dose
in the period 18–24 h after treatment indicates a pro-
longed duration of antidiabetic action and could be due
to multiple sites of action possessed by the active princi-
ples of C. roseus.
Alloxan, a beta-cytotoxin causes a massive destruction of
β-cells of the islets of Langerhans resulting in reduced syn-
thesis and release of insulin [24–26]. It is well established
that sulphonylureas produce hypoglycemia by increasing
the secretion of insulin from pancreas and these com-
pounds are active in mild alloxan-induced diabetes
whereas they are inactive in intense alloxan diabetes
(nearly all β-cells have been destroyed) [27,28]. Since our
results showed that glibenclamide reduced blood glucose
levels in hyperglycemic animals, the state of diabetes is
not severe. Alloxan-treated animals receiving the leaf juice
of C. roseus showed rapid normalization of blood glucose
levels in comparison to control and this could be due to
the possibility that some β-cells are still surviving to act
upon by C. roseus to exert its insulin releasing effect. More-
Table 1: Percentage blood glucose reduction produced by C. roseus after oral administration in normal rabbits.
Group
(n = 5)
Dose Initial 
Blood 
glucose 
(mg/dl)
Percent blood glucose reduction
4 6 8 10 12 16 18 20 24 (h)
Control --- 105.6 -3.1 ± 5.3 -2.4 ± 6.4 -0.4 ± 6.2 -3.6 ± 5.0 -6.9 ± 6.3 -4.5 ± 4.2 -0.4 ± 9.9 5.9 ± 1.5 -1.5 ± 4.6
C. roseus 0.50 ml/kg 99.2 11.5 ± 0.7* 16.7 ± 1.2* 15.3 ± 3.1 12.6 ± 2.4* 4.9 ± 8.0 4.6 ± 6.6 8.1 ± 2.1 8.9 ± 1.9 1.0 ± 4.4
C. roseus 0.75 ml/kg 101.4 13.9 ± 5.1* 17.1 ± 1.9* 19.5 ± 3.4* 19.7 ± 5.7* 22.8 ± 3.1** 27.0 ± 0.7*** 28.6 ± 0.4* 14.7 ± 6.2 4.3 ± 7.1
C. roseus 1.0 ml/kg 108.5 14.1 ± 3.3* 17.5 ± 3.2* 19.2 ± 2.6* 20.8 ± 6.1* 24.4 ± 4.4** 29.6 ± 4.2*** 30.7 ± 5.2* 31.9 ± 5.3** 30.0 ± 1.4***
Glibenclamide 40 µg/kg 104.2 25.5 ± 4.1** 29.7 ± 4.9** 31.9 ± 4.8** 29.8 ± 5.2** 28.3 ± 4.7** 23.1 ± 3.6** 21.9 ± 3.6 19.8 ± 5.4 17.3 ± 4.7
Values are mean percent blood glucose reduction (± S.E.M.) of five animals. Significant difference from control at corresponding intervals: *p < 0.05, 
**p < 0.01, ***p < 0.001
Table 2: Percentage blood glucose reduction produced by C. roseus after oral administration in alloxan-induced diabetic rabbits.
Group
 (n = 5)
Dose Initial 
Blood 
glucose 
(mg/dl)
Percent blood glucose reduction
4681 0 1 2 1 6 1 8 2 0 2 4  ( h )
Control --- 324.7 1.2 ± 0.3 0.7 ± 0.3 0.1 ± 0.3 -0.5 ± 0.4 -0.5 ± 0.2 0.2 ± 0.5 -0.6 ± 1.9 -0.7 ± 0.1 -0.2 ± 0.3
C. roseus 0.50 ml/kg 316.0 10.5 ± 1.9** 14.9 ± 0.8*** 19.6 ± 0.5*** 16.85 ± 0.8*** 13.4 ± 4.9** 8.9 ± 1.9** 7.7 ± 2.4* 6.3 ± 1.3*** 4.4 ± 1.6*
C. roseus 0.75 ml/kg 304.9 14.6 ± 4.5* 16.7 ± 2.5*** 22.2 ± 3.8*** 24.5 ± 7.4** 27.8 ± 6.5** 27.4 ± 3.5*** 31.4 ± 5.6*** 25.8 ± 5.1*** 19.4 ± 6.4*
C. roseus 1.0 ml/kg 319.2 16.8 ± 5.8* 20.9 ± 5.5** 24.1 ± 2.9*** 26.6 ± 4.9*** 27.5 ± 9.2* 30.4 ± 6.9* 32.7 ± 6.0*** 36.5 ± 4.8*** 31.8 ± 8.5**
Glibenclamide 40 µg/kg 323.9 22.6 ± 
3.6***
28.5 ± 5.5*** 34.9 ± 4.6*** 28.7 ± 6.5** 24.8 ± 5.7** 24.6 ± 4.1*** 21.3 ± 5.6** 17.4 ± 9.8 14.5± 5.9*
Values are mean percent blood glucose reduction (± S.E.M.) of five animals. Significant difference from control at corresponding intervals: *p < 0.05, 
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over, like sulphonylureas oral administration of C. roseus
produced hypoglycemia in normal animals. This suggests
that the mode of action of the active ingredients of C.
roseus is probably mediated by an enhanced secretion of
insulin, like sulphonylureas. However, the possibility that
enhanced tissue glucose utilization by C. roseus cannot be
ruled out. Further work is obviously required to fraction-
ate, purify and identify the active aqueous principle(s)
present in the leaves of Catharanthus roseus.
Conclusions
Our study clearly indicated a significant antidiabetic activ-
ity with the leaf juice of Catharanthus roseus and supports
the traditional usage of fresh leaves by the Ayurvedic phy-
sicians for the control of diabetes. Hence it might help in
preventing diabetic complications and serve as a good
adjuvant in the present armamentarium of antidiabetic
drugs.
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